FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...